Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Wednesday, November 26, 2008

1996 trimethylaminuria paper : What % of people would fail the trimethylaminuria urine test in a sample population ?

1996 pubmed paper: 3.8% fail the 90% trimethylaminuria urine test in a British sample of 421 people (Mitchell, Smith, Zhang - Imprerial College London)

Since there is no interest from the medical system in metabolic body odors and halitosis apart from some occasional studies into trimethylaminuria (There are 5 listed on pubmed for 'trimethylaminuria' this year. 10 last year. Most of little significance) done by researchers who study lots of other things. The only estimates used is probably a 'DNA estimate' by geneticists, who at the 1999 1st TMAU Workshop mentioned they thought maybe 1% could be at risk (it's unknown if they are going by the 'strict' interpretation, that all sufferers will be autosomal recessive e.g. homozygotes).

However, there was a substantial 'real' snapshop testing survey done amongst a sample 'normal' British population In 1996 at the Imperial college in London, by 3 researchers. They tested 421 students of Imperial College Medical School at St. Mary's, London using the TMAU urine test. In the UK, they define a 'fail' as being less than 90% TMA-N-Oxide produced, and less than 80% as being "indicative of potential heterozygous status for deficient N-oxidation-fish odour syndrome" (which is surprising to read, since if medical students were taught about TMAU, they would likely be taught it is autosomal recessive e.g. homozygous)

The results were:
421 of a UK sample population tested
16 failed the 90% test (3.8% : seven male, nine female)
6 failed the 80% test (1.4% : all female)

So in a sample British population, 3.8% failed the urine test. 1.4% were not near the borderline. Nowadays, some researchers feel that it will be likely that people can pass the urine test but fail the test "in vivo" (i.e. in practice). 2 of the researchers are well known for publishing TMAU papers (especially around that time and the following few years), although they both likely have many other lines of research, and this is the only part of metabolic body odor they will focus on whenever they choose to do research along this line.

It makes you wonder how, for example, a Body Odor & Halitosis Research and Treatment Center would have reacted to such a study at the time. And how far the issue would have progressed both in treatment and how governments and medical systems would now view the issue.


Post a Comment